Skip to main content

Syncona

data as at: 18/02/2020
ObjectiveTo deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Management groupSyncona Investment Managers
AIC sectorBiotechnology & Healthcare
Total assets (m)Price (last close)Price (bid)Price (offer)NAVDiscount/
premium (%)
Gearing (%)Dividend yield (%)
1,319.0245.50242.00250.00199.0023.400.9

This company is not currently a member of the AIC.  We are therefore unable to provide full company information at this time.

Data provided by Morningstar.